Sanofi and Regeneron's Dupixent scores a potential sales boost as AbbVie candidate threatens

18th September 2017 Uncategorised 0

Sanofi and Regeneron, whose Dupixent is slated to reach peak sales of at least $4 billion, keep pumping out new data that they hope will help get it there sooner rather than later.

More: Sanofi and Regeneron's Dupixent scores a potential sales boost as AbbVie candidate threatens
Source: fierce